CDK inhibitors may boost the effectiveness of immune therapy in metastatic breast can

[News]

A class of drugs that inhibits breast cancer progression when used with hormonal therapy might also boost the effectiveness of immune therapy in cases of recurrent, metastatic breast cancer, according to a new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

More... (https://www.news-medical.net/news/20210510/CDK-inhibitors-may-boost-the-effectiveness-of-immune-therapy-in-metastatic-breast-cancer.aspx)